Effectiveness of Adjuncts with Demineralized Freeze Dried Bone Allograft in Treatment of Intrabony Defects – A systematic review
DOI:
https://doi.org/10.15448/1980-6523.2015.4.18783Keywords:
Demineralized freeze dried bone allograft, Chronic periodontitis, Intrabony defect, Guided tissue regeneration, Antimicrobials, Immunosuppressive agents, Autologous platelet concentrate and Enamel matrix derivativeAbstract
Objective: To systematically evaluate the effect of adjuncts with demineralized freeze dried bone in the treatment of intrabony defects in terms of clinical and radiological outcomes.
Methods: A search was conducted for randomized controlled trials in cases of chronic periodontitis to evaluate the effect of adjuncts with demineralized freeze dried bone in the treatment of intrabony defects. The electronic databases like PUBMED and the Cochrane Central Register of Controlled Trials were used as data sources. Gain in clinical attachment level was considered as the primary outcome variable while Pocket depth reduction and Radiological bone fill were considered to be the secondary outcome variables.
Results: Of all the articles screened, seven controlled human clinical trials met the eligibility criteria and provided clinical and radiological outcome data on the effectiveness of adjuncts with Demineralized Freeze Dried Bone Allograft (DFDBA) in the treatment of intrabony defects. Amongst the above mentioned seven trials, three controlled clinical trial showed significant results while four controlled clinical trials did not show significant results. From this systematic review, it can be concluded that the treatment with Autologous Platelet Concentrate (PRP) in combined with DFDBA showed significant results in probing pocket depth reduction and clinical attachment level gain. Cyclosporine A in combination with DFDBA showed significant radiological bone fill and Enamel Matrix Derivative (EMD) in combination with DFDBA with 12 months followup showed significant soft tissue and hard tissue healing.
Conclusion: PRP in combination with DFDBA showed significant results in probing pocket depth reduction and clinical attachment level gain. Cyclosporine with DFDBA showed significant radiological bone fill and EMD in combination to DFDBA with 12 months follow-up showed significant soft tissue and hard tissue healing. However, long term studies are needed to clarify the effectiveness of adjuncts with DFDBA in the treatment of intrabony defect.
Downloads
Published
Issue
Section
License
COPYRIGHT
The submission of originals to Odonto Ciência implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Odonto Ciência as the site of original publication.
CREATIVE COMMONS LICENSE
As this journal is open access, the articles are allowed free use in scientific and educational applications, with citation of the source.
According to the type of Creative Commons License (CC-BY 4.0) adopted by Odonto Ciência, the user must respect the requirements below.
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
However, only under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests Odonto Ciência endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
For more details on the Creative Commons license, please follow the link in the footer of this website.
